Filing Flows › Orthofix Medical (OFIX) › Q2 FY25
Orthofix Medical (OFIX) Q2 FY25 earnings results (second quarter fiscal 2025)
10-Q filed Aug 5, 2025
Orthofix Medical (OFIX) reported revenue of $203M for the second quarter fiscal 2025 (Q2 FY25), +2% from a year earlier and +5% from the quarter before. Operating margin was -7.9%, net loss $14.1M (6.9% of revenue).
Orthofix Medical, Q2 FY25: revenue $203M (+2% year over year), operating margin -7.9%, net loss $14.1M, operating cash flow $11.6M. The chart follows the revenue to costs, profit and cash.
| Q2 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $203M | +5% | +2% |
| Operating profit | −$16.0M | — | — |
| Net earnings | −$14.1M | — | — |
| Operating cash flow | $11.6M | — | +30% |
| Free cash flow | $4.5M | — | — |
What changed
Revenue was $203.1M in Q2 FY25, up 2% year over year and up 5% from the previous quarter. Global Spine was the largest line at 84% of revenue. Global Orthopedics added $2.7M year over year (up 9%), 60% of the total change.
Gross margin was 68.7%, up 0.9 points from a year earlier. Operating costs exceeded revenue by $16.0M, an operating margin of -7.9%. Operating expenses fell 3% while revenue rose 2%. The quarter ended with a net loss of $14.1M, narrower than the previous quarter's $53.1M loss.
Operating cash flow was $11.6M (up 30% year over year). Non-cash charges added back $16.9M of depreciation and amortization and $7.8M of share-based compensation. Working capital and other items added $1.0M. Capital expenditures of $7.1M left free cash flow of $4.5M.
Questions
What was Orthofix Medical's revenue in the second quarter fiscal 2025?
Orthofix Medical (OFIX) reported revenue of $203M for the second quarter fiscal 2025 (Q2 FY25), +2% from a year earlier and +5% from the quarter before.
Was Orthofix Medical profitable in the second quarter fiscal 2025?
Operating loss was $16.0M (-7.9% of revenue) and net loss $14.1M.
Source: Orthofix Medical 10-Q on SEC EDGAR.